Jaye Thompson, the VP Clinical Reg Affairs of $GLSI ($GLSI), bought 1,000 shares of the company on 11-21-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings by approximately 0.4%. Following this trade, they now own 264,148 shares of $GLSI stock.
$GLSI Insider Trading Activity
$GLSI insiders have traded $GLSI stock on the open market 9 times in the past 6 months. Of those trades, 9 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $GLSI stock by insiders over the last 6 months:
- JAYE THOMPSON (VP Clinical Reg Affairs) has traded it 4 times. They made 4 purchases, buying 3,800 shares and 0 sales.
- SNEHAL PATEL (CEO and CFO) has traded it 5 times. They made 5 purchases, buying 185,325 shares and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$GLSI Hedge Fund Activity
We have seen 21 institutional investors add shares of $GLSI stock to their portfolio, and 19 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORTHERN TRUST CORP added 50,180 shares (+206.3%) to their portfolio in Q3 2024
- GOLDMAN SACHS GROUP INC removed 41,505 shares (-100.0%) from their portfolio in Q2 2024
- BLACKROCK, INC. added 41,235 shares (+13.3%) to their portfolio in Q3 2024
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 35,870 shares (-100.0%) from their portfolio in Q2 2024
- JANE STREET GROUP, LLC removed 20,642 shares (-100.0%) from their portfolio in Q2 2024
- GARDEN STATE INVESTMENT ADVISORY SERVICES LLC added 17,600 shares (+inf%) to their portfolio in Q3 2024
- QUBE RESEARCH & TECHNOLOGIES LTD removed 17,317 shares (-100.0%) from their portfolio in Q2 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
